Relatively limited, but intensive, research efforts in this area led to several families of potent 5-HT6R ligands [4,5], which have been proposed for potential treatment in the cognitive dysfunction associated with Alzheimer’s disease, anxiety or depression [5,6,7]. This evidence concerns the gene HTR6 and depressive symptom measurement.